Abstract
Adherence to controller medication for persistent asthma is often suboptimal, contributing to uncontrolled symptoms and higher economic burden. We describe contemporary adherence estimates among a large, diverse real-world sample of US patients with asthma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have